Anti-emetic quinuclidinyl benzamides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4820715
SERIAL NO

07051880

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel substituted benzamides of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and A are as defined herein are useful in the treatment of emesis, and particularly chemotherapy-induced emesis in cancer patients. Some of the compounds are also useful in disorders relating to impaired gastric motility.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRISTOL-MYERS COMPANY345 PARK AVENUE NEW YORK NEW YORK 10154

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Monkovic, Ivo Fayetteville, NY 10 169
Willner, David Dewitt, NY 9 647

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation